CNS Pharmaceuticals News and Activities

View the org chart displaying its 11 main executives

Most searched biographies at CNS Pharmaceuticals

• Rami Levin, Chief Executive Officer and Director
• George Gumulka, Independent Director
• Bettina Cockroft, Independent Director

Popular executive movements at CNS Pharmaceuticals

• Dylan Wenke has joined the company as Chief Business Officer  (posted on March 4 2026).
• Sandra Silberman, Chief Medical Officer, has left the company  (posted on March 4 2026).
• Steve O'Loughlin has joined the company as Chief Financial Officer  (posted on March 4 2026).

Click here to view some more movements at CNS Pharmaceuticals

Create your alert
to follow the executive moves at CNS Pharmaceuticals.

CNS Pharmaceuticals has 2,428 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Eli Lilly has announced the acquisition of AtaiBeckley  (posted on July 17 2026).
• GSK has acquired Nuvalent (posted on July 17 2026).
• Clearside Biomedical has gone out of its bankruptcy protection  (posted on July 15 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by CNS Pharmaceuticals

• Press Releases | CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• CNS Pharmaceuticals
• View more press releases Close

Social media about CNS Pharmaceuticals

• CNS Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• CNS Pharmaceuticals on LinkedIn, X (Twitter) & YouTube